RASTETTER WILLIAM H

Average Profitability
<0.0001%
Insider Buys Quantity
8
Insider Buys Sum
$4.92M
Insider Sells Quantity
23
Insider Sells Sum
$29.68M

Insider Activity of RASTETTER WILLIAM H

According to the SEC Form 4 filings, RASTETTER WILLIAM H, being in a position of

  1. director at Neurocrine Biosciences, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 25294 shares for $3.54M,
    over all time since 2017-02-01, has bought 0 shares, and sold 67509 shares for $7.03M.

The largest purchase of all time was on 2016-11-23 and amounted to 751878 shares of Fate Therapeutics, Inc. for $2M.

The largest sale of all time was on 2005-02-15 and amounted to 120313 shares of Biogen Inc. for $8.15M.

Biography of RASTETTER WILLIAM H

No biography is available at this moment.

2024-08-15SaleNeurocrine Biosciences, Inc.
NBIX
director
14,250
0.0141%
$146.69$2.09M0%
2024-01-02SaleNeurocrine Biosciences, Inc.
NBIX
director
11,044
0.0112%
$131.47$1.45M+2.48%
2023-05-01SaleNeurocrine Biosciences, Inc.
NBIX
director
4,300
0.0043%
$101.43$436,135+9.01%
2023-04-21SaleNeurocrine Biosciences, Inc.
NBIX
director
6,034
0.0063%
$105.04$633,787+7.95%
2023-04-19SaleNeurocrine Biosciences, Inc.
NBIX
director
903
0.0009%
$105.00$94,819+7.22%
2022-04-01SaleNeurocrine Biosciences, Inc.
NBIX
10,728
0.0111%
$94.93$1.02M+8.11%
2019-05-07PurchaseRegulus Therapeutics Inc.
RGLS
director
92,889
0.5004%
$1.08$100,320-40%
2018-01-24SaleNeurocrine Biosciences, Inc.
NBIX
director
9,500
0.0108%
$90.00$855,000+4.72%
2017-07-25PurchaseRegulus Therapeutics Inc.
RGLS
director
274,725
0.2501%
$0.91$250,000-17.12%
2017-03-07PurchaseRegulus Therapeutics Inc.
RGLS
director
250,000
0.4718%
$1.15$287,500+2.61%
2017-02-01SaleNeurocrine Biosciences, Inc.
NBIX
director
10,750
0.0122%
$42.28$454,510+25.91%
2016-11-23PurchaseFate Therapeutics, Inc.
FATE
director
751,878
1.6334%
$2.66$2M+11.55%
2015-07-21PurchaseRegulus Therapeutics Inc.
RGLS
director
61,235
0.1176%
$10.19$624,199-33.01%
2015-07-20PurchaseRegulus Therapeutics Inc.
RGLS
director
38,765
0.0726%
$10.13$392,779-34.13%
2015-01-20SaleIllumina, Inc.
ILMN
director
16,000
0.0107%
$188.99$3.02M-1.83%
2014-09-29SaleIllumina, Inc.
ILMN
director
248
0.0002%
$163.73$40,605+17.21%
2014-06-30SaleIllumina, Inc.
ILMN
director
334
0.0002%
$174.34$58,230+5.39%
2014-04-21SaleIllumina, Inc.
ILMN
director
879
0.0006%
$135.82$119,386+27.7%
2014-04-15PurchaseDaré Bioscience, Inc.
DARE
director
37,738
0.2385%
$7.00$264,166-11.51%
2014-03-31SaleIllumina, Inc.
ILMN
director
296
0.0002%
$143.50$42,476+19.65%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.